Filing Details
- Accession Number:
- 0001209191-21-063219
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-05 17:16:20
- Reporting Period:
- 2021-10-01
- Accepted Time:
- 2021-11-05 17:16:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1695580 | Kenneth Krogulski | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-10-01 | 85 | $2.69 | 177,440 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-04 | 85 | $2.87 | 177,525 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-05 | 85 | $2.82 | 177,610 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-06 | 85 | $2.76 | 177,695 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-07 | 85 | $2.76 | 177,780 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-08 | 85 | $2.84 | 177,865 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-11 | 85 | $2.73 | 177,950 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-12 | 85 | $2.71 | 178,035 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-13 | 85 | $2.71 | 178,120 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-14 | 85 | $2.81 | 178,205 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-15 | 85 | $2.76 | 178,290 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-18 | 85 | $2.75 | 178,375 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-19 | 85 | $2.76 | 178,460 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-20 | 85 | $2.63 | 178,545 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-21 | 85 | $2.65 | 178,630 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-22 | 85 | $2.66 | 178,715 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-25 | 85 | $2.64 | 178,800 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-26 | 85 | $2.64 | 178,885 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-27 | 85 | $2.61 | 178,970 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-28 | 85 | $2.61 | 179,055 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-10-29 | 85 | $2.72 | 179,140 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
Billionaire Hedge Funds
